Review



pim 1 inhibitor tp 3654  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress pim 1 inhibitor tp 3654
    FIGURE <t>2</t> <t>TP-3654</t> enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib
    Pim 1 Inhibitor Tp 3654, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pim+1+inhibitor+tp+3654/TP-3654/10__1158_slash_2767___9764__crc___23___0379-64-8-11
    Average 94 stars, based on 7 article reviews
    pim 1 inhibitor tp 3654 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation"

    Article Title: Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation

    Journal: Cancer Research Communications

    doi: 10.1158/2767-9764.crc-23-0379

    FIGURE 2 TP-3654 enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib
    Figure Legend Snippet: FIGURE 2 TP-3654 enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib

    Techniques Used: In Vivo, Injection, Control

    Related Articles

    Inhibition:

    Article Title: Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation
    Article Snippet: The FLT3 inhibitor gilteritinib (ASP2215; MedChemExpress, #HY-12432) was used at clinically relevant ( ) concentrations of 10 or 15 nmol/L in in vitro experiments, consistent with concentrations that inhibited FLT3 and STAT5 inhibition in cells with FLT3-ITD ( ) and IC 50 concentrations in cells with FLT3-ITD ( ) and concentrations used in vitro in prior literature ( ). .. The pan-Pim inhibitor AZD1208 (Tocris Bioscience, #6310) and Pim-1 inhibitor TP-3654 (MedChemExpress, #HY-101126) were both used at 1 μmol/L based on inhibition of p-BAD (S112) at this concentration ( ). .. The GSK-3β inhibitor TC-G 24 (Tocris, #4353) was used at 17 nmol/L based on GSK-3β inhibition ( ).

    Article Title: Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation
    Article Snippet: The FLT3 inhibitor gilteritinib (ASP2215; MedChemExpress, #HY-12432) was used at clinically relevant (29) concentrations of 10 or 15 nmol/L in in vitro experiments, consistent with concentrations that inhibited FLT3 and STAT5 inhibition in cells with FLT3-ITD (30, 31) and IC50 concentrations in cells with FLT3-ITD (24, 30, 31) and concentrations used in vitro in prior literature (24, 30, 31). .. The pan-Pim inhibitor AZD1208 (Tocris Bioscience, #6310) and Pim-1 inhibitor TP-3654 (MedChemExpress, #HY-101126) were both used at 1 μmol/L based on inhibition of p-BAD (S112) at this concentration (32, 33). .. The GSK3β inhibitor TC-G 24 (Tocris, #4353) was used at 17 nmol/L based on GSK-3β inhibition (24).

    Concentration Assay:

    Article Title: Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation
    Article Snippet: The FLT3 inhibitor gilteritinib (ASP2215; MedChemExpress, #HY-12432) was used at clinically relevant ( ) concentrations of 10 or 15 nmol/L in in vitro experiments, consistent with concentrations that inhibited FLT3 and STAT5 inhibition in cells with FLT3-ITD ( ) and IC 50 concentrations in cells with FLT3-ITD ( ) and concentrations used in vitro in prior literature ( ). .. The pan-Pim inhibitor AZD1208 (Tocris Bioscience, #6310) and Pim-1 inhibitor TP-3654 (MedChemExpress, #HY-101126) were both used at 1 μmol/L based on inhibition of p-BAD (S112) at this concentration ( ). .. The GSK-3β inhibitor TC-G 24 (Tocris, #4353) was used at 17 nmol/L based on GSK-3β inhibition ( ).

    Article Title: Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation
    Article Snippet: The FLT3 inhibitor gilteritinib (ASP2215; MedChemExpress, #HY-12432) was used at clinically relevant (29) concentrations of 10 or 15 nmol/L in in vitro experiments, consistent with concentrations that inhibited FLT3 and STAT5 inhibition in cells with FLT3-ITD (30, 31) and IC50 concentrations in cells with FLT3-ITD (24, 30, 31) and concentrations used in vitro in prior literature (24, 30, 31). .. The pan-Pim inhibitor AZD1208 (Tocris Bioscience, #6310) and Pim-1 inhibitor TP-3654 (MedChemExpress, #HY-101126) were both used at 1 μmol/L based on inhibition of p-BAD (S112) at this concentration (32, 33). .. The GSK3β inhibitor TC-G 24 (Tocris, #4353) was used at 17 nmol/L based on GSK-3β inhibition (24).



    Similar Products

    pim 1 inhibitor tp 3654  (MedChemExpress)
    94
    MedChemExpress pim 1 inhibitor tp 3654
    FIGURE <t>2</t> <t>TP-3654</t> enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib
    Pim 1 Inhibitor Tp 3654, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pim+1+inhibitor+tp+3654/TP-3654/10__1158_slash_2767___9764__crc___23___0379-64-8-11
    Average 94 stars, based on 1 article reviews
    pim 1 inhibitor tp 3654 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 2 TP-3654 enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib

    Journal: Cancer Research Communications

    Article Title: Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation

    doi: 10.1158/2767-9764.crc-23-0379

    Figure Lengend Snippet: FIGURE 2 TP-3654 enhances efficacy of gilteritinib in vivo. NRG mice injected intravenously with MV4-11-luc cells were treated with gilteritinib and/or TP-3654, or vehicle control, with first treatment day defined as day 1. A, Serial images of mice in first experiment, treated with gilteritinib

    Article Snippet: The pan-Pim inhibitor AZD1208 (Tocris Bioscience, #6310) and Pim-1 inhibitor TP-3654 (MedChemExpress, #HY-101126) were both used at 1 μmol/L based on inhibition of p-BAD (S112) at this concentration (32, 33).

    Techniques: In Vivo, Injection, Control